Table 3.
Microbiological findings—SARS-CoV-2 infection
| No. (Total n = 13,932) | No. (%) | |
|---|---|---|
| Confirmed COVID-19 | 13,932 | 13,932 (100.0) |
| Acquisition of COVID-19 | ||
| Community | 13,870 | 11,806 (85.1) |
| Nosocomial | 908 (6.6) | |
| Nursing home | 1156 (8.3) | |
| Source of positive sample for SARS-CoV-2 | ||
| Nasopharyngeal swab | 13,672 | 13,396 (98.0) |
| Sputum | 224 (1.6) | |
| Bronchoalveolar lavage (BAL) | 52 (0.4) | |
| Results of the first PCR | ||
| Negative | 13,723 | 1660 (12.1) |
| Positive | 12,063 (87.9) | |
| Results of urine antigens | ||
| Negative | 13,570 | 6168 (45.5) |
| Any positive | 198 (1.5) | |
| Positive Pneumococcus | 179 (1.3) | |
| Positive Legionella | 12 (0.1) | |
| Both positive | 7 (0.1) | |
| Not performed | 7204 (53.1) | |
| HIV serology test | ||
| Not performed | 13,793 | 5860 (42.5) |
| Negative | 7844 (56.9) | |
| Positive | 89 (0.7) | |